A5064508743- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- COVID-19 and healthcare impacts
- Cardiac electrophysiology and arrhythmias
- Health Systems, Economic Evaluations, Quality of Life
- Coronary Interventions and Diagnostics
- Cardiac tumors and thrombi
- Cardiac pacing and defibrillation studies
- Peripheral Artery Disease Management
- COVID-19 Clinical Research Studies
- Cardiac Arrhythmias and Treatments
- Long-Term Effects of COVID-19
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Ion channel regulation and function
- Cerebrovascular and Carotid Artery Diseases
- Veterinary medicine and infectious diseases
- Adrenal and Paraganglionic Tumors
- Parathyroid Disorders and Treatments
- Viral Infections and Immunology Research
- Cardiac Structural Anomalies and Repair
- Cardiovascular Syncope and Autonomic Disorders
- Medical Imaging and Pathology Studies
- ECG Monitoring and Analysis
- Amyloidosis: Diagnosis, Treatment, Outcomes
Saint Louis University Hospital
2023-2024
Saint Louis University
2023-2024
Heart Rhythm Society
2023
Indiana University – Purdue University Indianapolis
2020
Indiana University School of Medicine
2020
This spotlight article gives two clinical case examples for the implementation of a suggested safe and feasible strategy to implant leadless pacemakers instead changing generators transvenous with depleted batteries in elderly patients.
We present the first reported case of left ventricular assist device (LVAD) pump thrombosis in setting coronavirus pandemic. describe clinical features which helped to differentiate disease 19 (COVID-19) from LVAD thrombosis. The patient is 56-year-old female supported by destination therapy. She was originally implanted with a HeartMate II 2015 and underwent two exchanges 2017 2019 for thrombosis, despite medication adherence. Shortly after routine lab work revealed near doubling her...
Endovascular revascularization (EVR) is a treatment option for chronic total occlusion in peripheral artery disease (CTO-PAD). However, there lack of data regarding the rates amputation and outcomes following this procedure The National Readmission Database was queried between 2016 2020 to identify patients ≥18 with CTO-PAD who underwent endovascular revascularization. Surgically re-vascularized were excluded. Outcomes defined as post-index major amputations. We identified 92,433 CTO-PAD;...
We aimed to determine the incidence and mortality rates of in-stent restenosis (ISR) stent thrombosis (STS) within 30 days in patients who underwent PCI (Percutaneous Coronary Intervention) as an elective procedure (PCI-E) versus following myocardial infarction (PCI- MI). From 2016 2020, we queried National Readmission Database identify initial hospitalization for PCI. excluded less than 18 years. Of PCI-E (n= 342,644) PCI-MI 1,107,614) groups, identified 44,999 107,947 patients,...
Coronary in-stent restenosis (ISR) is a major clinical challenge of contemporary percutaneous revascularization and portends adverse cardiovascular outcomes.
Background Despite the known benefits for individuals with heart failure (HF), incomplete data suggest a low use of palliative care (PC) HF in United States. We aimed to investigate national PC adults by determining when they received their first consultation (PCC) and associations clinical factors following diagnosis HF. Methods Results conducted retrospective cohort study all‐payer electronic health record database identify (aged ≥18 years) newly diagnosed between 2011 2018. The proportion...
Background: Cardiac implantable electronic device (CIED) infections pose risks, with outcomes potentially influenced by underlying comorbidities such as end-stage renal disease (ESRD). Objective: To evaluate the differences in clinical of CIED-infection management between patients and without ESRD. Methods: From 2016 to 2020, we employed National Readmission Database identify ≥18 years age who were admitted CIED-related infections. CIED/lead extraction was defined a composite device, or...
Background: Primary malignant cardiac tumors (PMCT) pose a unique clinical challenge due to their rarity, limited treatment options, and aggressive disease course. The aim of this study is understand characteristics survival rates based on initial presentation patients admitted with PMCTs. Methods: From 2016 2020, we employed the National Readmission Database identify individuals ≥18 years age who were initially diagnosis PMCT. Kaplan-Meier analysis was reported as hazard ratios estimate...